PFS Improved With Kyprolis Over Velcade for Multiple Myeloma
Michelle Bragazzi, BS, RN 3/4/2015 0
Patients with relapsed multiple myeloma treated with carfilzomib (Kyprolis) in combination with low-dose dexamethasone lived twice as long without their disease worsening, ...
Survey: Occupational Exposure to Anticancer Agents
Michelle Bragazzi, BS, RN 3/3/2015 0
We know how much you love surveys here on TheONC, and this time we would like to help out a future nurse learn more about occupational exposure in oncology.
FDA Approves New Multiple Myeloma Drug
Melissa Scott, BSN, RN, OCN 2/27/2015 2
The US Food and Drug Administration (FDA) recently expedited approval for another cancer drug. On February 23, 2015, the FDA approved panobinostat (Farydak), a third-line treatment ...
Net Worth Impacts Hormone Therapy Compliance in Breast Cancer Patients
Michelle Bragazzi, BS, RN 2/25/2015 4
While white women are more likely to be diagnosed with breast cancer, more black women die from the disease. Furthermore, when it comes to hormone medication for early-stage breast ...
Linda M. Gorman
Elusive Advance Care Planning
Linda M. Gorman, RN, MN, PMHCNS-BC, CHPN, FPCN, OCN 2/23/2015 1
Advance care planning remains the missing link in many patients' treatment plans as they face serious illnesses. While there are more resources available these days, such as ...
FDA Grants Early Approval to Lenvatinib for Treatment of Thyroid Cancer
Michael Kaufman, Medical Journalist 2/19/2015 1
The U.S. Food and Drug Administration (FDA) granted expedited approval on February 13, 2015 to the oral kinase inhibitor lenvatinib (Lenvima) for use in patients with progressive, ...
UV ProtectionóIt's Not Just for the Summer Months
Lori Smith, BSN, MSN, CRNP 2/17/2015 2
When we think of skin cancer prevention, most of us automatically think of making sure we have sunscreen on hand when we are at the beach. In all honesty, I never really thought of ...
Neulasta Administration Just Got Easier
Katherine Mitchell, APRN, AOCNP 2/13/2015 3
You are likely familiar with the granulocyte-colony stimulating factor (G-CSF) medication pegfilgrastim (Neulasta), used to help stimulate the bone marrow's production of white ...
Taking Cancer Care to Heart
Monica Key, APRN, CCRN, AOCNP 2/12/2015 12
This month is abounding with hearts due to Valentine's Day -- and due to the American Heart Association having designated February American Heart Month. How are we, in oncology, ...